Pivotal Study of the Velocity™ pAVF System
Eligible age
18–80 yrs
Accepts
All genders
Locations
7 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This study will evaluate the Velocity Percutaneous Arteriovenous Fistula (pAVF) System, a new minimally invasive method for creating dialysis access. People with kidney failure often require dialysis, which depends on having a reliable arteriovenous fistula (AVF). Traditionally, AVFs are created with surgery, but surgery can involve incisions, longer recovery, and sometimes additional procedures before the AVF can be used. The Velocity System is designed to create an AVF through a small puncture in the skin using a catheter-based approach, without open surgery. This pivotal study will assess how safe the procedure is and how well it works for patients who need dialysis. The study will take place at multiple centers in the United States and will enroll adults with kidney failure who are candidates for fistula creation. Participants will undergo the Velocity procedure and then be followed closely with exams, ultrasounds, and dialysis assessments for up to five years. Taking part is voluntary. Patients may benefit from a less invasive approach to dialysis access, but the main goal is to collect information that could improve future care for people with kidney failure.
Sponsor: Venova Medical
You may qualify if…
- ✓ 1. ESRD requiring hemodialysis access or CKD with anticipated need for hemodialysis within 6 months
- ✓ 2. Cubital perforating vein diameter ⩾ 2.0 and ⩽ 5.0 mm
- ✓ 3. Proximal radial artery diameter ⩾ 2.0 and ⩽ 4.0 mm
- ✓ 4. Age \> 18 years and \< 80 years
- ✓ 5. Willing and competent to give written informed consent
- ✓ 6. Willing and able to complete all study assessments and follow-up requirements
You may not qualify if…
- ✕ 1. Study extremity systolic blood pressure \< 100mmHg
- ✕ 2. Subjects with occlusion of the ulnar or radial artery at any level or an abnormal Allen's test
- ✕ 3. Subjects with a previous ipsilateral arterio-venous graft or previous ipsilateral upper arm AVF.
- ✕ 4. Distance between Cubital Perforating Vein and Proximal Radial Artery \> 3.0 mm
- ✕ 5. Cephalic vein diameter \< 2.5 mm at any point from the CPV to the axillary vein
- ✕ 6. Central venous occlusion ipsilateral of the study extremity
- ✕ 7. Severe calcification of the radial artery that significantly impairs ultrasound visualization (e.g., acoustic shadowing) and thus precludes safe or accurate device deployment.
- ✕ 8. Evidence of active systemic infections or localized to the procedure access site within the past 7 days
Where it's recruiting
Dothan
Concord · Riverside
Cocoa · Jacksonville
Staten Island
Charlotte
Orangeburg
Houston · Humble · San Antonio
Source: ClinicalTrials.gov · NCT07153939 · last updated 2026-07-27